RAM
SQZ

Redmond Asset Management’s SQZ Biotechnologies Company SQZ Stock Holding History

Redmond Asset Management’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-17,206
Closed -$154K – 202
2021
Q4 		$154K Buy
17,206
+770
+5% +$9.44K 0.04% 191
2021
Q3 		$237K Hold
16,436
– – 0.07% 175
2021
Q2 		$238K Hold
16,436
– – 0.07% 180
2021
Q1 		$224K Buy
+16,436
New +$334K 0.07% 184

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Redmond Asset Management's SQZ Position: Q1 2022 in Review

Redmond Asset Management sold out of SQZ Biotechnologies Company (SQZ) in Q1 2022, closing a stake of 17,206 shares — an estimated $154K sold.

Redmond Asset Management first reported a position in SQZ in Q1 2021 and held it in 4 quarters. The position peaked at $238K in Q2 2021. 53 funds tracked by Wall St. Rank hold SQZ as of Q1 2022.

  • Redmond Asset Management reported no remaining SQZ Biotechnologies Company position as of Q1 2022 after selling out during the quarter.
  • Redmond Asset Management sold 17,206 SQZ Biotechnologies Company shares in Q1 2022, an estimated $154K.
  • Redmond Asset Management first reported a position in SQZ Biotechnologies Company in Q1 2021 and held it in 4 quarters.
  • Redmond Asset Management's SQZ Biotechnologies Company position peaked at $238K in Q2 2021.
  • 53 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q1 2022.

Based on Redmond Asset Management's 13F filing for Q1 2022, filed 3 May 2022.